Brief: Prostatype Genomics Says Net Sales For Q3 Amounted To Approx 530 Tsek, Compared To 109 Tsek For Same Period Last Year
21/12/2023 17:35
Dec 21 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* NET SALES FOR Q3 OF 2023 AMOUNTED TO APPROX. 530 TSEK,
COMPARED
TO 109 TSEK FOR SAME PERIOD LAST YEAR
Source text for Eikon: ID:nWkr81673X
Further company coverage: PROGEN.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants